Flora Growth Corp. (FLGC)
Company Info
CA3397641026
339764102
May 11, 2021
Highlights
$15.46M
-$0.96
$53.26M
$11.53M
-$12.83M
$0.42 - $2.11
$2.75
1.05%
0.77
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
Flora Growth Corp. (FLGC) returned -34.95% year-to-date (YTD) and -45.97% over the past 12 months.
FLGC
-34.95%
14.14%
-61.49%
-45.97%
-67.76%
N/A
N/A
^GSPC (Benchmark)
0.51%
6.15%
-2.00%
12.92%
12.68%
14.19%
10.85%
Monthly Returns
The table below presents the monthly returns of FLGC, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | -24.37% | -3.15% | -19.81% | -2.98% | 14.14% | -34.95% | |||||||
| 2024 | -18.52% | 10.91% | 89.34% | -26.84% | -31.95% | -11.30% | -1.96% | 3.00% | 48.54% | -6.21% | 21.25% | -40.80% | -23.70% |
| 2023 | 28.30% | 50.68% | -33.23% | -27.06% | 9.52% | -49.30% | 9.24% | 47.31% | -69.71% | -32.15% | 46.11% | 17.39% | -70.34% |
| 2022 | -3.93% | 19.88% | -4.39% | -23.47% | -33.33% | -39.00% | 4.41% | 39.77% | -20.73% | -12.14% | -25.81% | -50.52% | -87.21% |
| 2021 | -16.08% | -7.46% | 110.75% | 19.01% | -39.44% | -23.54% | -53.01% | -12.32% | -62.84% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of FLGC is 24, meaning it’s performing worse than 76% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Flora Growth Corp. (FLGC) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the Flora Growth Corp.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Flora Growth Corp. was 99.87%, occurring on Apr 10, 2025. The portfolio has not yet recovered.
The current Flora Growth Corp. drawdown is 99.81%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.87% | Aug 16, 2021 | 918 | Apr 10, 2025 | — | — | — |
| -39.25% | May 12, 2021 | 47 | Jul 19, 2021 | 6 | Jul 27, 2021 | 53 |
| -20.14% | Aug 4, 2021 | 1 | Aug 4, 2021 | 4 | Aug 10, 2021 | 5 |
| -15.36% | Jul 29, 2021 | 1 | Jul 29, 2021 | 3 | Aug 3, 2021 | 4 |
| -3.58% | Aug 12, 2021 | 1 | Aug 12, 2021 | 1 | Aug 13, 2021 | 2 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Flora Growth Corp. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Flora Growth Corp., comparing actual results with analytics estimates. In the past quarter, the company did not meet analyst expectations for EPS, resulting in a surprise of -270.3%.
Valuation
The Valuation section provides an overview of how Flora Growth Corp. is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for FLGC relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, FLGC has a P/S ratio of 0.3. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for FLGC in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, FLGC has a P/B value of 3.2. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |